Drug Development Medications Drug Treatments Diabetes Medications Monoclonal Antibodies Antibiotics GLP-1 Receptor Agonists Drug Effects Drug Mechanisms Anticoagulants
Phase 2 results showing stable biomarkers with improved cognition in genetically at-risk patients pave the way for a larger cognition-focused study later this year.